Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
16 mai 2024 08h00 HE
|
Fortress Biotech, Inc.
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
15 mai 2024 16h01 HE
|
Journey Medical Corporation
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses...
GRI Bio Announces Pricing of $5.5 Million Public Offering
02 févr. 2024 08h00 HE
|
GRI Bio, Inc.
LA JOLLA, CA, Feb. 02, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell...
Bukit Jalil Global Acquisition 1 Ltd. Announces the Separate Trading of its Ordinary Shares, Warrants, and Rights, Commencing on August 21, 2023
17 août 2023 08h00 HE
|
Bukit Jalil Global Acquisition 1 Ltd.
New York, NY, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Bukit Jalil Global Acquisition 1 Ltd. (the “Company”) (Nasdaq: BUJA), a blank check company, today announced that, commencing on August 21, 2023,...
CELSION CORPORATION ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
06 avr. 2022 08h30 HE
|
Celsion Corporation
LAWRENCEVILLE, NJ, April 06, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional...
Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock
10 janv. 2022 20h45 HE
|
Celsion CORP
LAWRENCEVILLE, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today...
Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
01 déc. 2021 15h25 HE
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced the closing of its previously announced registered direct offering with certain...
MICHAEL SHILLIN INVESTOR ALERT: National Investor Fraud Law Firm KlaymanToskes Commences Investigation of Financial Advisor Michael Shillin in Light of SEC lawsuit and FINRA bar
28 oct. 2021 16h53 HE
|
Klayman & Toskes P.A.
WISCONSIN, Oct. 28, 2021 (GLOBE NEWSWIRE) -- National investor fraud law firm, KlaymanToskes (“KT”), has commenced an investigation of potential FINRA arbitration claims of financial advisor Michael...
Coda Octopus Group to Present Fireside Chat with Alliance Global Partners
20 sept. 2021 06h00 HE
|
Coda Octopus Group, Inc.
ORLANDO, FL, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (CODA) (Nasdaq: CODA) a global leader in real time 3D/4D/5D and 6D underwater imaging technologies, announced today that its...
Muscle Maker, Inc. Announces $10 Million Private Placement Priced At-The-Market
07 avr. 2021 08h30 HE
|
Muscle Maker, Inc.
League City, Texas, April 07, 2021 (GLOBE NEWSWIRE) -- Muscle Maker, Inc. (Nasdaq: GRIL) (“Muscle Maker” or the “Company”) today announced it has entered into a definitive agreement for a private...